Detalhe da pesquisa
1.
Primary central nervous system lymphoma.
Blood
; 140(9): 971-979, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699590
2.
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.
JAMA
; 329(7): 574-587, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809318
3.
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.
BMC Cancer
; 22(1): 60, 2022 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027038
4.
Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies.
Eur J Nucl Med Mol Imaging
; 48(12): 3940-3950, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966087
5.
DNA Repair Mechanisms and Therapeutic Targets in Glioma.
Curr Oncol Rep
; 23(8): 87, 2021 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125307
6.
Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.
J Neurooncol
; 146(1): 163-170, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823165
7.
Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression.
Pediatr Dermatol
; 36(4): 497-500, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30868657
8.
Updates on Primary Central Nervous System Lymphoma.
Curr Oncol Rep
; 20(2): 11, 2018 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492682
9.
A Review of Glioblastoma and Other Primary Brain Malignancies-Reply.
JAMA
; 330(2): 189-190, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432433
10.
Bruton's tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances.
Leuk Lymphoma
; : 1-13, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597202
11.
State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond.
Am Soc Clin Oncol Educ Book
; 44(3): e431450, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723228
12.
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS Lymphoma.
JCO Oncol Pract
; : OP2400080, 2024 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38917404
13.
Central Nervous System Lymphoma.
Continuum (Minneap Minn)
; 29(6): 1710-1726, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085895
14.
Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant.
Neurology
; 101(7): e710-e716, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344228
15.
Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma.
Leuk Lymphoma
; 64(9): 1545-1553, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317993
16.
Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort.
Ann Lymphoma
; 72023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067886
17.
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases.
Clin Cancer Res
; 29(4): 775-783, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449664
18.
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series.
Neurology
; 2022 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948444
19.
Update on Novel Therapeutics for Primary CNS Lymphoma.
Cancers (Basel)
; 13(21)2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771535
20.
Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies.
Ann Lymphoma
; 52021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912868